Investing in PMV Pharmaceuticals Inc (PMVP) Is Getting More Attractive

In a filing, PMV Pharmaceuticals Inc revealed its 10% Owner ORBIMED ADVISORS LLC unloaded Company’s shares for reported $0.2 million on Nov 22. In the deal valued at $2.23 per share,87,786 shares were sold. As a result of this transaction, ORBIMED ADVISORS LLC now holds 0 shares worth roughly $0.0.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.
Sponsored

Then, Alland Leila sold 6,291 shares, generating $41,646 in total proceeds. Upon selling the shares at $6.62, the Chief Medical Officer now owns 45,909 shares.

Before that, Jalota Deepika sold 4,104 shares. PMV Pharmaceuticals Inc shares valued at $27,168 were divested by the Chief Development Officer at a price of $6.62 per share. As a result of the transaction, Jalota Deepika now holds 29,946 shares, worth roughly $50309.28.

Ladenburg Thalmann initiated its PMV Pharmaceuticals Inc [PMVP] rating to a Buy in a research note published on December 27, 2023; the price target was $7.

Price Performance Review of PMVP

On Friday, PMV Pharmaceuticals Inc [NASDAQ:PMVP] saw its stock fall -0.59% to $1.68. Over the last five days, the stock has lost -5.62%. PMV Pharmaceuticals Inc shares have fallen nearly -45.81% since the year began. Nevertheless, the stocks have fallen -77.66% over the past one year. While a 52-week high of $9.72 was reached on 01/02/24, a 52-week low of $1.17 was recorded on 01/19/24. SMA at 50 days reached $2.2478, while 200 days put it at $4.5593. A total of 0.81 million shares were traded, compared to the trading of 0.6 million shares in the previous session.

Levels Of Support And Resistance For PMVP Stock

The 24-hour chart illustrates a support level at 1.6467, which if violated will result in even more drops to 1.6133. On the upside, there is a resistance level at 1.7217. A further resistance level may holdings at 1.7633. The Relative Strength Index (RSI) on the 14-day chart is 33.31, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.0492, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 77.14%. Stochastics %K at 35.26% indicates the stock is a holding.

How much short interest is there in PMV Pharmaceuticals Inc?

A steep rise in short interest was recorded in PMV Pharmaceuticals Inc stocks on Jan 31, 2024, growing by 0.13 million shares to a total of 1.75 million shares. Yahoo Finance data shows the prior-month short interest on Dec 29, 2023 was 1.62 million shares. There was a rise of 7.43%, which implies that there is a positive sentiment for the stock. In spite of short shares comprising just 4.02% of the overall stock float, the days-to-cover ratio (short ratio) rose to 4.15.

Leave a Reply

Your email address will not be published. Required fields are marked *

Most Popular